Literature DB >> 20809220

Intestinal damage in enterohemorrhagic Escherichia coli infection.

Zivile D Békássy1, Carla Calderon Toledo, Gustav Leoj, Anncharlotte Kristoffersson, Shana R Leopold, Maria-Thereza Perez, Diana Karpman.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) infection leads to marked intestinal injury. Sigmoid colon obtained from two children during EHEC infection exhibited abundant TUNEL-positive cells. To define which bacterial virulence factors contribute to intestinal injury the presence of Shiga toxin-2 (Stx2), intimin and the type III secretion system were correlated with symptoms and intestinal damage. C3H/HeN mice were inoculated with Stx2-producing (86-24) and non-producing (87-23) E. coli O157:H7 strains and 86-24 mutants lacking eae, encoding intimin (strain UMD619) or escN regulating the expression of type III secretion effectors (strain CVD451). Severe symptoms developed in mice inoculated with 86-24 and 87-23. Few mice inoculated with the mutant strains developed severe symptoms. Strain 86-24 exhibited higher fecal bacterial counts, followed by 87-23, whereas strains UMD619 and CVD451 showed minimal fecal counts. More TUNEL-positive cells were found in proximal and distal colons of mice inoculated with strain 86-24 compared with strains 87-23 and CVD451 (p ≤ 0.01) or UMD619 (p < 0.05, proximal colon, p < 0.01, distal colon). The results show that strains 86-24 and 87-23 exhibited better colonic persistence and more symptoms, presumably due to the presence of intimin and type III secretion effectors. Extensive intestinal mucosal cell death was related to the presence of Stx2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809220     DOI: 10.1007/s00467-010-1616-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  54 in total

1.  Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Authors:  B P Hurley; M Jacewicz; C M Thorpe; L L Lincicome; A J King; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Role of EspF in host cell death induced by enteropathogenic Escherichia coli.

Authors:  J K Crane; B P McNamara; M S Donnenberg
Journal:  Cell Microbiol       Date:  2001-04       Impact factor: 3.715

3.  Verocytotoxin-induced apoptosis of human microvascular endothelial cells.

Authors:  Antonetta H J M Pijpers; Petra A VAN Setten; Lambertus P W J VAN DEN Heuvel; Karel J M Assmann; Hendrikus B P M Dijkman; Arie H M Pennings; Leo A H Monnens; Victor W M VAN Hinsbergh
Journal:  J Am Soc Nephrol       Date:  2001-04       Impact factor: 10.121

4.  Shiga toxin binding in normal and inflamed human intestinal mucosa.

Authors:  Stephanie Schüller; Robert Heuschkel; Franco Torrente; James B Kaper; Alan D Phillips
Journal:  Microbes Infect       Date:  2006-12-15       Impact factor: 2.700

5.  The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection.

Authors:  D Karpman; H Connell; M Svensson; F Scheutz; P Alm; C Svanborg
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

Review 6.  Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements.

Authors:  G Frankel; A D Phillips; I Rosenshine; G Dougan; J B Kaper; S Knutton
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

7.  Antibody response of patients infected with verocytotoxin-producing Escherichia coli to protein antigens encoded on the LEE locus.

Authors:  C Jenkins; H Chart; H R Smith; E L Hartland; M Batchelor; R M Delahay; G Dougan; G Frankel
Journal:  J Med Microbiol       Date:  2000-01       Impact factor: 2.472

8.  Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves.

Authors:  E A Dean-Nystrom; B T Bosworth; W C Cray; H W Moon
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

9.  Interaction of enterohemorrhagic Escherichia coli O157:H7 with mouse intestinal mucosa.

Authors:  Francis Girard; Gad Frankel; Alan D Phillips; William Cooley; Ute Weyer; Alexandra H A Dugdale; Martin J Woodward; Roberto M La Ragione
Journal:  FEMS Microbiol Lett       Date:  2008-04-16       Impact factor: 2.742

10.  Enzyme-linked immunosorbent assay for detection of Shiga toxin-producing Escherichia coli infection by antibodies to Escherichia coli secreted protein B in children with hemolytic uremic syndrome.

Authors:  A-C Sjögren; J B Kaper; A Caprioli; D Karpman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

View more
  21 in total

1.  The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor.

Authors:  Jeffrey D Galley; Zhongtang Yu; Purnima Kumar; Scot E Dowd; Mark Lyte; Michael T Bailey
Journal:  Gut Microbes       Date:  2014

2.  Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7.

Authors:  K A Eaton; C Fontaine; D I Friedman; N Conti; C J Alteri
Journal:  Vet Pathol       Date:  2017-02-08       Impact factor: 2.221

Review 3.  Citrobacter rodentium(ϕStx2dact), a murine infection model for enterohemorrhagic Escherichia coli.

Authors:  Cheleste M Thorpe; Amanda R Pulsifer; Marcia S Osburne; Sivapriya Kailasan Vanaja; John M Leong
Journal:  Curr Opin Microbiol       Date:  2021-12-17       Impact factor: 7.584

4.  Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease.

Authors:  Steven D Zumbrun; Angela R Melton-Celsa; Mark A Smith; Jeremy J Gilbreath; D Scott Merrell; Alison D O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

5.  Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).

Authors:  Myda Khalid; Sharon Andreoli
Journal:  Pediatr Nephrol       Date:  2018-11-01       Impact factor: 3.714

6.  Lettuce-derived secretory IgA specifically neutralizes the Shiga toxin 1 activity.

Authors:  Katsuhiro Nakanishi; Minami Matsuda; Ryota Ida; Nao Hosokawa; Kohta Kurohane; Yasuo Niwa; Hirokazu Kobayashi; Yasuyuki Imai
Journal:  Planta       Date:  2019-06-20       Impact factor: 4.116

7.  Annexin Induces Cellular Uptake of Extracellular Vesicles and Delays Disease in Escherichia coli O157:H7 Infection.

Authors:  Ashmita Tontanahal; Ida Arvidsson; Diana Karpman
Journal:  Microorganisms       Date:  2021-05-26

Review 8.  Escherichia coli Shiga Toxins and Gut Microbiota Interactions.

Authors:  Kyung-Soo Lee; Yu-Jin Jeong; Moo-Seung Lee
Journal:  Toxins (Basel)       Date:  2021-06-11       Impact factor: 4.546

9.  Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed.

Authors:  Diana Karpman
Journal:  Nephrol Dial Transplant       Date:  2012-10       Impact factor: 5.992

10.  The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.

Authors:  Milan Chromek; Ida Arvidsson; Diana Karpman
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.